MBCT vs Mindfulness-Based Relapse Prevention

A side-by-side comparison of recorded mechanisms, evidence review status, related condition topics, and philosophical roots.

At a glance

Source checks, condition-specific assessments and expert review are separate steps. Each assessment applies only to its stated population and use. Topic links do not establish comparative effectiveness.

MBCT

Tradition
Cognitive-Behavioral
Founder
Segal / Williams / Teasdale (2002)
Review status
1 condition assessment available
Official sources
Guidelines and official sources (14)

13 clinical guideline checks · 1 evidence registry check

Read the recommendation and its scope. A source may discuss an approach without recommending it.

  • Depression in adults: treatment and management (NG222)

    NICE · 2022 · Clinical guideline · 1.8.5–1.8.6

    Recommendation for the stated population

    NICE lists group MBCT as a relapse-prevention option, with or without continuing antidepressants according to preference.

    Scope: People remitted on antidepressants alone and at higher relapse risk

    Source checked

  • Mindfulness-based cognitive therapy

    Society of Clinical Psychology (APA Division 12; American Psychological Association) · Current archive, 1998 criteria; 2015 re-evaluation pending · Evidence registry · 1998 EST Status; 2015 EST Status

    Discussed in the source

    The archive lists Strong under 1998 criteria and pending 2015 re-evaluation.

    Scope: MBCT; depression/relapse prevention evidence

    Source checked

  • Depression in adults: treatment and management (NG222)

    NICE · 2022 · Clinical guideline · Recommendation 1.5.2; Table 1: group mindfulness and meditation

    Recommendation for the stated population

    NICE includes group mindfulness and meditation using a programme such as MBCT among treatment options. This is separate from its relapse-prevention recommendations.

    Scope: Adults with a new episode of less severe depression; depression-specific group programme.

    Source checked

  • Clinical Practice Guideline for Management of PTSD and Acute Stress Disorder

    VA/DoD · 2023 · Clinical guideline · Recommendation 27; Table 6, p.38

    Insufficient evidence for or against

    VA/DoD finds insufficient evidence for or against MBCT for PTSD.

    Scope: Adults with PTSD; mind-body interventions.

    Source checked

  • Management of Major Depressive Disorder

    VA/DoD · Version 4.0, February 2022; evidence through January 2021 · Clinical guideline · Recommendation 7; pp.23,35–36

    Recommendation for the stated population

    VA/DoD suggests mindfulness-based cognitive therapy among seven unranked psychotherapy options (weak for). Treatment strategy also depends on severity, chronicity, prior response and preference.

    Scope: Adults with uncomplicated MDD choosing psychotherapy.

    Source checked

  • Management of Major Depressive Disorder

    VA/DoD · Version 4.0, February 2022; evidence through January 2021 · Clinical guideline · Recommendations 23 and 7; pp.25,56

    Discussed in the source

    VA/DoD strongly recommends first-line evidence-based psychotherapy, referring to the list that includes mindfulness-based cognitive therapy. This is a class-level recommendation, with no preferred individual approach.

    Scope: Pregnant or breastfeeding adults with mild-to-moderate MDD.

    Source checked

  • Management of Major Depressive Disorder

    VA/DoD · Version 4.0, February 2022; evidence through January 2021 · Clinical guideline · Recommendation 22; pp.25,55

    Recommendation for the stated population

    VA/DoD suggests MBCT during continuation treatment to reduce relapse or recurrence (weak for). CBT, IPT and MBCT are not ranked against one another.

    Scope: Remitted MDD with high risk of relapse or recurrence.

    Source checked

  • Clinical Practice Guideline for the Management of Chronic Multisymptom Illness

    VA/DoD · May 2021; version 3.0 · Clinical guideline · Recommendation 4; pp.20, 27–28; Appendix J, p.107

    Discussed in the source

    The guideline discusses an IBS adaptation of MBCT within a weak recommendation for mindfulness-based therapies. This is not a separate recommendation for standard MBCT across all chronic multisymptom illnesses.

    Scope: MBCT adapted for IBS within the chronic multisymptom illness guideline.

    Source checked

  • Management of Headache

    US Department of Veterans Affairs / Department of Defense · Version 3.0; September 2023; evidence through 2022-08-16 · Clinical guideline · Recommendation 44; table p.40; mindfulness discussion p.114

    Discussed in the source

    The recommendation is neutral for the mindfulness-based therapy category; the discussion includes MBCT. It does not assign MBCT a separate recommendation grade.

    Scope: Mindfulness-based interventions for headache treatment or prevention.

    Source checked

  • Tinnitus

    US Department of Veterans Affairs / Department of Defense · Version 1.0; June 2024; evidence through 2023-04-07 · Clinical guideline · Recommendation 15; mindfulness discussion p.62

    Discussed in the source

    The guideline is neutral for mindfulness-based therapies. MBCT appears in the evidence discussion, without a separate MBCT recommendation grade.

    Scope: Mindfulness-based therapies for adults with bothersome tinnitus.

    Source checked

  • Management of Type 2 Diabetes Mellitus

    VA/DoD · Version 6.0, May 2023 · Clinical guideline · Recommendation 17 discussion; pp.55–57

    Discussed in the source

    The review includes MBCT within mindfulness/acceptance interventions. The graded recommendation concerns a stress-reduction programme category, without a separate MBCT grade or established long-term benefit.

    Scope: Adults with stress related to type 2 diabetes.

    Source checked

  • Clinical Practice Guideline for Management of Stroke Rehabilitation

    VA/DoD · May 2024; version 5.0 · Clinical guideline · Recommendation 42; pp.31, 97–99

    Discussed in the source

    VA/DoD weakly recommends mindfulness-based therapies and specifically reviews MBSR and MBCT. The recommendation is for the therapy family in this post-stroke population.

    Scope: Depression following stroke.

    Source checked

  • Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts

    American Psychological Association · 2019 · Clinical guideline · Table 3, printed p.10

    Discussed in the source

    APA includes MBCT among broadly comparable models; it cannot recommend a superior monotherapy.

    Scope: Adults with depressive disorders, excluding psychotic depression; initial monotherapy selection.

    Source checked

  • Clinical Practice Guideline for Tobacco Use Treatment

    VA/DoD · January 2026; version 3.0 · Clinical guideline · Recommendation 28; Table 4, p.38; discussion pp.70–72

    Discussed in the source

    VA/DoD weakly recommends against standalone mindfulness for this cessation goal. This is category-level guidance; MBCT is not separately graded, and the statement does not address adjunctive use or other conditions.

    Scope: Mindfulness used as a standalone treatment for abstinence from tobacco or nicotine.

    Source checked

Focus
Skill + Experiential
Format
Group
Duration
Short (8-week)

Condition-specific assessments

Each conclusion applies to the population and use described. These source-based assessments do not certify the full entry or replace expert clinical review.

Depression & Mood Disorders

Population and scope: Adults with uncomplicated MDD, or remitted MDD with high relapse risk.

Guideline recommendation

VA/DoD 2022 weakly includes MBCT for initial psychotherapy selection (recommendation 7) and separately for continuation after remission in patients at high relapse risk (22). Neither recommendation establishes superiority; acute treatment and relapse prevention are distinct scopes.

Source assessment dated

Mindfulness-Based Relapse Prevention

Tradition
Contemplative
Founder
Sarah Bowen / Neha Chawla / G. Alan Marlatt (2010)
Review status
3 source checks available
Official sources
Guidelines and official sources (3)

3 clinical guideline checks

Read the recommendation and its scope. A source may discuss an approach without recommending it.

  • Clinical Practice Guideline for the Management of Substance Use Disorders

    VA/DoD · August 2021; version 5.0 · Clinical guideline · Recommendation 30; pp.33, 75–76

    Insufficient evidence for or against

    VA/DoD finds insufficient evidence for or against mindfulness-based therapies. It discusses MBRP directly, but does not make a positive recommendation for it.

    Scope: Mindfulness-based therapies, including MBRP, for substance-use disorders.

    Source checked

  • Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders

    World Health Organization · Third edition, 20 November 2023 · Clinical guideline · ALC2, pp. 13–14 (PDF pp. 45–46)

    Discussed in the source

    Mindfulness-based relapse prevention is discussed within the reviewed psychosocial interventions. WHO conditionally recommends structured psychosocial treatment as a group, with low-certainty evidence, while noting uncertainty about individual therapy types versus usual care.

    Scope: Adults with alcohol dependence.

    Source checked

  • Clinical Practice Guideline for Tobacco Use Treatment

    VA/DoD · January 2026; version 3.0 · Clinical guideline · Recommendation 28; Table 4, p.38; discussion pp.70–72

    Discussed in the source

    VA/DoD weakly recommends against standalone mindfulness for this cessation goal. This is category-level guidance; MBRP is not separately graded, and the statement does not address adjunctive use or other conditions.

    Scope: Mindfulness used as a standalone treatment for abstinence from tobacco or nicotine.

    Source checked

Focus
Mindfulness + Relapse Prevention
Format
Group (8-12)
Duration
Short-term (8-week group)

How they work

MBCT

Core mechanism: Mindful awareness of depressive cognitive patterns enables decentering and prevents ruminative relapse spirals

Ontology: Depressive relapse maintained by reactivation of ruminative cognitive patterns triggered by low mood

Mindfulness-Based Relapse Prevention

Core mechanism: Mindfulness practice builds awareness of triggers, craving, and habitual reaction patterns; decentering from substance-related thoughts and urge surfing break the automaticity of relapse cycles

Ontology: Relapse is driven by automatic cognitive-affective-behavioral chains: craving triggers habitual responding before conscious choice can intervene; mindfulness inserts a gap between stimulus and response

Related condition topics

These editorial cross-references organize reading. A shared link does not mean both approaches are effective, recommended, or interchangeable for that condition.

0 shared · 2 MBCT-only · 1 Mindfulness-Based Relapse Prevention-only

Linked only in the Mindfulness-Based Relapse Prevention entry

What each assumes — and misses

MBCT

Philosophical roots: Buddhist psychology (mindfulness, non-attachment to thoughts); Husserl (epoché: suspending natural attitude); Kabat-Zinn (secularized dharma); Teasdale (interacting cognitive subsystems)

Blind spots: Primarily relapse prevention: not first-line for acute depression; requires meditation capacity some clients lack

Therapeutic voice: Notice the thought arriving, not as truth, but as a mental event. Thoughts are not facts.

Mindfulness-Based Relapse Prevention

Philosophical roots: Buddhist psychology (impermanence of craving, mindfulness as investigation); Marlatt (cognitive-behavioral relapse prevention model); Kabat-Zinn (MBSR); Teasdale (decentering, metacognitive awareness); Segal (cognitive reactivity)

Blind spots: Requires sustained meditation practice many clients find difficult; built as aftercare, so it assumes a period of stabilization rather than meeting people mid-crisis; 8-week group format may miss individual complexity; the mindfulness component has to be delivered by someone with a practice of their own, which limits how far it can be disseminated

Therapeutic voice: You're not trying to make it go away. You're staying with it while it moves. Where is it right now, still building or already coming down?

Choosing between them

MBCT (Cognitive-Behavioral) and Mindfulness-Based Relapse Prevention (Contemplative) come from different traditions, which means they assume different things about what a person is, what causes suffering, and what the therapeutic relationship is for. The choice between them is often less about "which works better" and more about which set of assumptions fits the client and the therapist.

For deeper coverage: see the full MBCT and Mindfulness-Based Relapse Prevention pages, or use the interactive comparison tool to add more modalities to this comparison.